Le Lézard
Classified in: Health, Business
Subject: TNM

Laborie Medical Technologies Acquires Pelvalon


PORTSMOUTH, N.H., Oct. 13, 2021 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie) a specialist medical technology company, announced today that it has acquired Pelvalon, Inc., a privately held medical device company located in Redwood City, CA.

Pelvalon has developed an innovative product called the Eclipsetm System, a non-surgical, patient-controlled device for women suffering from fecal incontinence (FI). FI is a pelvic floor disorder that affects one in ten women. The Eclipse has a compelling clinical profile validated in multiple studies, is FDA-cleared and has established reimbursement. The product is simple, safe and effective and its reputation has spurred demand from numerous healthcare professionals and patients across the country.

"Laborie's mission every day is to operate as a world-class specialist medical company making and advancing technologies that preserve and restore human dignity," said Michael Frazzette, President & CEO of Laborie. "Our mission is well served by the addition of Eclipsetm to help patients who suffer from this difficult condition."

"I am grateful for the dedicated work of my colleagues to bring the therapy to this point, and we are delighted that Laborie will be able to scale and deliver Eclipsetm to the doctors and patients who need it," said Miles Rosen, Pelvalon Founder and CEO. "Laborie's mission aligns perfectly with this technology."

"Patricia Industries is committed to supporting Laborie in its mission to provide patients and healthcare professionals with innovative and effective therapeutic and diagnostic technologies that preserve and restore human dignity," said Yuriy Prilutskiy, Head of Patricia Industries North America, a part of Investor AB, and owner of Laborie. "This acquisition further supports Laborie's long-term growth, leverages Patricia Industries' healthcare and life sciences expertise and aligns with our organization's purpose of creating value for people and society by building strong and sustainable businesses."

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

About Laborie Medical Technologies

Headquartered in Portsmouth, New Hampshire, Laborie is a global medical technology company focused on Urology, Urogynecology, Gastroenterology, Obstetrics, Gynecology & Neonatal Health.

We manufacture and deliver high-quality, high-impact diagnostic and therapeutic products that help clinicians and hospitals preserve and restore patient dignity.

Clinicians and hospitals look to us as the market-leading experts in our business segments, and we support our products with a world-class Clinical Education & Information program. For more information visit www.laborie.com.

About Pelvalon

Headquartered in Redwood City, California, Pelvalon aims to improve the lives of women who suffer from pelvic floor disorders, conditions that commonly impact women as they age. The company was founded by Miles Rosen and Steve Herbowy.  It spun out of Stanford University's Biodesign program and is backed by Norwich Ventures and other investors.

About Patricia Industries

Patricia Industries is a long-term owner that invests in companies and works to develop each company to its full potential. Patricia Industries is a part of the industrial holding company Investor AB, whose main owners are the Wallenberg foundations.

About Investor AB

Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies. We have a long-term investment perspective. Through board participation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class.

SOURCE LABORIE MEDICAL TECHNOLOGIES, CORP.


These press releases may also interest you

at 01:15
-- UCB to partner with Novartis on development of UCB0599 with an opt-in to develop UCB7853, two innovative and potentially disease-modifying investigational assets in Parkinson's disease -- UCB will receive upfront payment of US$150 million and is...

at 01:02
Immensitas Private Limited has raised $2.3M in a Pre-Series A1 round co-led by growx ventures, Artha Venture Fund (AVF), and DSP Investment Managers Pvt. Ltd. The round also saw participation from LogX Ventures and Atrium Angels, the ISB alumni...

at 01:00
TEKLYNX International, known for its software to help companies around the world barcode better, announces new partnership with OPAL Associates Holding AG.  This partnership further enhances the functionality of barcode label design, management, and...

at 01:00
Dr. Karl Pankratz performed robot-assisted total knee replacement surgery today at Covenant High Plains Surgery Center (CHPSC), expanding the program to many more West Texas patients seeking high-quality, cost-effective outpatient knee replacement...

at 00:05
Atmofizer Technologies Inc. (the "Company" or "Atmofizer") is pleased to announce that the Company has entered into a non-exclusive distribution agreement with USA Rapid Test, LLC ("USA Rapid Test") under which USA Rapid Test has placed an initial...

at 00:01
ATTOM, curator of the nation's premier property database, today released its third-quarter 2021 U.S. Residential Property Mortgage Origination Report, which shows that 3.59 million mortgages secured by residential property (1 to 4 units) were...



News published on 13 october 2021 at 08:00 and distributed by: